&

Pacific Meso Center adds Wong to research team

Monday, June 11, 2012 03:42 PM

The Pacific Meso Center (PMC), a division of the Pacific Heart, Lung & Blood Institute focused on research and treatment of malignant pleural mesothelioma (MPM), has appointed Dr. Raymond M. Wong, PhD, as its new scientific researcher.

More... »

ISTA stockholders approve acquisition by Bausch + Lomb

Wednesday, June 6, 2012 10:05 AM

At a special meeting on Tuesday, June 5, ISTA Pharmaceuticals stockholders voted to approve the merger of ISTA and Bausch & Lomb.

More... »

CMO revenue could double in Europe, says Frost & Sullivan

Thursday, May 31, 2012 03:10 PM

New analysis from Frost & Sullivan, "European Pharmaceutical and Biotech Contract Manufacturing Markets," finds that the European pharmaceutical contract manufacturing market earned revenues of $10.02 billion in 2011 and estimates this to reach $20.75 billion in 2018. Over the same period, the European biotech contract manufacturing market is set to expand from $1.21 billion to an estimated $2.67 billion.

More... »

Biopharmas that attract corporate venture investment more likely to be acquired, go public, analysis finds

Wednesday, May 30, 2012 10:42 AM

Therapeutics companies that attract investment from corporate venture arms are more likely than other venture-backed companies to enter licensing deals, be acquired or complete an initial public offering, according to analysis from Burrill & Company, a diversified global financial services firm focused on the life sciences industry.

More... »

J&J China acquires Guangzhou Bioseal Biotech

Friday, May 4, 2012 08:01 AM

Johnson & Johnson China Investment has acquired Guangzhou Bioseal Biotech, a privately held biopharmaceutical company specializing in the design, development and commercialization of a porcine plasma-derived biologic product for controlling bleeding during surgery. Financial terms of the transaction are not being disclosed. 

More... »

Report: Pharmaceutical market grew by 5.3% in 2011

Friday, April 20, 2012 12:29 PM

Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, found that in 2011, the global pharmaceutical market, in dollar terms, benefitted significantly from positive currency effects.

More... »

Mymetics ropes in Dendreon vets

Wednesday, April 11, 2012 12:58 PM

Mymetics, a Swiss-based biotech of mucosal and virosomal-based vaccines for infectious diseases, has appointed Grant E. Pickering as president and CEO and Christopher S. Henney as chairman of the board of directors. The changes were made in connection with Mymetics’ efforts to obtain additional financing and to advance the development of its vaccine platform.

More... »

Analysis: U.S. CMO market reviving, offering preclinical services

Tuesday, April 10, 2012 11:27 AM

The upturn in the fortunes of pharmaceutical companies after the recession is mirrored by the U.S. contract manufacturing outsourcing (CMO) market, which is expected to grow at a compound annual growth rate of 8.3% from 2011 to 2016, according to Frost & Sullivan's newest analysis of the U.S. CMO market.

More... »

Burrill wraps up life sciences industry for Q1 2012

Wednesday, April 4, 2012 03:00 PM

Burrill & Company, a diversified global financial services firm focused on the life sciences industry, has identified more than $2.6 billion in expected funding through nine translational research and early-stage initiatives announced since the end of February.

More... »

Bausch + Lomb acquires ISTA Pharmaceuticals

Wednesday, March 28, 2012 10:47 AM

Bausch + Lomb, the global eye health company, has signed a definitive agreement to buy ISTA Pharmaceuticals for $9.10 per share in cash, or an approximate total of $500 million. The transaction was unanimously approved by the boards of directors of both companies and is expected to close in the second quarter of 2012.

More... »